RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31

Regenerative Medical Technology Group Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026

$0.04−0.00 (-5.76%)

Close on Oct 19, 2026

Market cap: $497.25K
P/E (TTM): –
Dividend yield: –

Regenerative Medical Technology Group Inc. balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31
Cash & Equivalents	0.96	1.17	0.53	1.65	2.98	0.04	0.02	0.03	0.01	0.01
Cash & Short-Term Investments	0.96	1.17	0.53	1.65	2.98	0.04	0.02	0.03	0.01	0.01
Receivables	0.04	0.02	0.02	0.05	0.02	–	–	–	–	–
Inventory	0.16	0.01	–	–	–	–	–	–	–	–
Prepaid Expenses & Other	0.06	0.05	0.02	–	0.04	0.18	–	–	–	–
Total Current Assets	1.22	1.25	0.57	1.69	3.02	0.04	0.02	0.03	0.01	–
Property, Plant & Equipment	0.87	0.45	0.36	0.19	0.02	0.00	0.00	0.00	–	–
Gross Property, Plant & Equipment	–	–	0.17	–	–	–	–	–	–	–
Accumulated Depreciation	-0.62	-0.43	-0.31	-0.10	-0.04	0.00	0.00	0.00	–	–
Operating Lease Right-of-Use Assets	0.62	0.28	0.00	0.03	–	–	–	–	–	–
Goodwill	1.68	1.68	1.68	5.81	5.81	–	–	–	–	–
Intangible Assets	0.06	0.16	0.26	0.35	0.45	–	–	–	–	–
Other Long-Term Assets	0.03	0.01	0.01	0.01	–	–	–	–	–	–
Total Assets	4.49	3.82	2.88	8.08	9.31	0.22	0.03	0.03	0.01	–
Accounts Payable	–	1.27	0.42	0.25	0.18	0.38	0.42	0.38	0.37	–
Accrued Expenses	17	11	6.60	4.66	2.13	0.39	–	0.44	0.37	–
Current Portion of Leases	0.22	0.06	0.00	0.03	–	–	–	–	–	–
Deferred Revenue (Current)	0.35	0.06	0.00	–	–	–	–	–	–	–
Other Current Liabilities	–	–	–	–	0.02	–	–	–	–	–
Total Current Liabilities	38	29	22	12	4.22	0.91	6.97	4.57	2.57	–
Long-Term Debt	2.00	2.00	0.04	0.01	12	–	–	–	–	–
Long-Term Leases	0.41	0.21	–	0.00	–	–	–	–	–	–
Operating Lease Liabilities	0.63	0.28	0.00	0.03	–	–	–	–	–	–
Total Liabilities	41	31	25	20	16	6.55	7.30	4.57	2.57	–
Total Debt	2.00	2.00	0.04	0.01	12	–	–	–	–	–
Preferred Stock	–	–	–	0.00	0.00	0.00	0.08	–	–	–
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	–
Additional Paid-In Capital	40	40	40	40	40	27	21	21	21	–
Retained Earnings	-76	-68	-62	-52	-47	-34	-28	-25	-23	–
Shareholders' Equity	-36	-27	-22	-12	-6.76	-6.41	-7.36	-4.54	-2.56	-5.51
Total Equity	-36	-27	-22	-12	-6.76	-6.41	-7.36	-4.54	-2.56	-5.51
Total Liabilities & Equity	4.49	3.82	2.88	8.08	9.31	0.22	0.03	0.03	0.01	–
Shares Outstanding(shares)	13	13	12	12	12	11	7.96	4.90	3.74	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 59.8%
Operating margin: 0.5%
Net margin: -101.2%
Return on equity, FY2025: 24.6%

Financial strength

Current ratio: 0.05
Debt to equity: -0.05
Debt to assets: 34.2%
Cash to current liabilities: 3.1%

Valuation

P/E ratio: –
Price to sales: 0.05
Price to book: –
Dividend yield: –